Brendon M. Fusco

Hematology

111 E 210th St
Bronx, NY 10467

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 4 publications

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

Efficacy of post-transplant brentuximab vedotin maintenance by pre-transplant disease status in relapsed/refractory classic Hodgkin lymphoma.

Journal: Blood cancer journal

Published: July 15, 2025

Prophylactic Vancomycin in the Primary Prevention of Clostridium difficile in Allogeneic Stem Cell Transplant.

Prophylactic Vancomycin in the Primary Prevention of Clostridium difficile in Allogeneic Stem Cell Transplant.

Journal: Transplant infectious disease : an official journal of the Transplantation Society

Published: September 25, 2024

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.

Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.

Journal: Blood advances

Published: July 19, 2023

Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.

Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.

Journal: American journal of hematology

Published: November 07, 2022

Showing 1-4 of 4

Last Updated: 09/26/2026